BRAFV600E mutant, PD-L1 TPS 90% NSCLC: 1st line treatment with targeted therapy
@article{PCM5969,
author = {Edwin H. Yau},
title = {BRAFV600E mutant, PD-L1 TPS 90% NSCLC: 1st line treatment with targeted therapy},
journal = {Precision Cancer Medicine},
volume = {4},
number = {0},
year = {2021},
keywords = {},
abstract = {},
issn = {2617-2216}, url = {https://pcm.amegroups.org/article/view/5969}
}